REGENERATIVE MEDICINE MARKET ANALYSIS

Leading Companies

Key Developments

1. Key players in the market are focused on various business strategies such as product launches, in order to expand their product portfolio and gain competitive edge in the market. For instance, in March 2019, Fidia Pharma USA Inc., a pharmaceutical company, launched NuDYN product, which is a regenerative medicine. This is company’s product in first regenerative medicine category.
2. Major companies in the market are focused no various business strategies business and capacity expansion, in order to enhance the global market presence. For instance, in May 2019, CollPlant, a regenerative medicine company, launched a new headquarter and research and development center Israel. The new R&D facility will serve COllPlant for development its product pipeline such as Biolinks for 3D bioprinting of organs and tissues.
3. Regulatory authorities and government organizations are engaged in launching various programs, in order to boost growth of global regenerative medicine market. For instance, in January 2017, the U.S. Food and Drug Administration (FDA) launched a new designation program for regenerative medicine therapies. This ‘Regenerative Medicine Therapy (RMAT) Designation’ program will foster the approval and development of regenerative medicine products.